Drug General Information
Drug ID
D0Q0HR
Former ID
DCL001041
Drug Name
Y-931
Drug Type
Small molecular drug
Indication Schizophrenia [ICD9: 295; ICD10:F20] Terminated [536463]
Company
Mitsubishi Pharma
Structure
Download
2D MOL

3D MOL

Formula
C24H23FN4O4S
Canonical SMILES
C[NH+]1CC[N+](=C2C3=C(NC4=C(N2)C=CC(=C4)F)SC5=CC=CC=C53<br />)CC1.C(=CC(=O)[O-])C(=O)[O-]
InChI
1S/C20H19FN4S.C4H4O4/c1-24-8-10-25(11-9-24)19-18-14-4-2-3-5-17(14)26-20(18)23-16-12-13(21)6-7-15(16)22-19;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3,(H,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-
InChIKey
RHPQQODEPSPFTF-BTJKTKAUSA-N
CAS Number
CAS 221058-55-5
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Binder [536463]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholism
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Reactome Dopamine receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.